Concepedia

Shannon M. Pfeiffer

SM

4

Publications

465

Citations

4

H-Index

2022

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Memorial Sloan Kettering Cancer Center

Dana-Farber Cancer Institute

Stanford University

Parker Institute for Cancer Immunotherapy

Shannon M. Pfeiffer is an author at Bristol-Myers Squibb (United States) specializing in medicine, radiation oncology, and tumor biology.

Top concepts

MedicineRadiation OncologyOncologyPathologyImmunologyImmunotherapyTumor BiologyTumor ImmunityTumor MicroenvironmentAutoimmunity

Publications per year

2022–2024

4

Publications

4

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Lacey Padrón, Deena M. Maurer, Mark H. O’Hara et al. · Nature Medicine · 2022 · 316 citations · Full text

Randomized Phase 2, Pancreatic Cancer, Gastrointestinal Oncology +13

Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma

Katie M. Campbell, Meelad Amouzgar, Shannon M. Pfeiffer et al. · Cancer Cell · 2023 · 72 citations · Full text

Aggregate Resource, Immunology, Pathology +16

Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade

Bridget M. Fortin, Shannon M. Pfeiffer, Jacob Insua‐Rodríguez et al. · Nature Immunology · 2024 · 67 citations · Full text

Cancer Immunosurveillance, Circadian Control, Tumor Immunosuppression +12

Real‐world data prognostic model of overall survival in patients with advanced <scp>NSCLC</scp> receiving anti‐<scp>PD</scp>‐1/<scp>PD‐L1</scp> immune checkpoint inhibitors as second‐line monotherapy

Cristina Julián, Robson Machado, Sandhya Girish et al. · Cancer Reports · 2022 · 10 citations · Full text

Rows per page

1–4 of 4